Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Parkinson's Disease

Free Subscription Articles published in Neurobiol Dis Retrieve available abstracts of 64 articles: HTML format Text format

Single Articles

January 2012
1. ISLAM R , Yang L, Sah M, Kannan K, et al
   A neuroprotective role of the human uncoupling protein 2 (hUCP2) in a Drosophila Parkinson's Disease model.
   Neurobiol Dis. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. MOURADIAN MM
   MicroRNAs in Parkinson's disease.
   Neurobiol Dis. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MCDOWELL K , Chesselet MF
   Animal models of the non-motor features of Parkinson's disease.
   Neurobiol Dis. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. GALLAGHER DA , Schrag A
   Psychosis, apathy, depression and anxiety in Parkinson's disease.
   Neurobiol Dis. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
5. LOW K , Aebischer P
   Use of viral vectors to create animal models for Parkinson's disease.
   Neurobiol Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. DOTY RL
   Olfaction in Parkinson's disease and related disorders.
   Neurobiol Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. SOREQ L , Ben-Shaul Y, Israel Z, Bergman H, et al
   Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways.
   Neurobiol Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. GOLDBERG NR , Fields V, Pflibsen L, Salvatore MF, et al
   Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
   Neurobiol Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
9. DELAVILLE C , Chetrit J, Abdallah K, Morin S, et al
   Emerging dysfunctions consequent to combined monoaminergic depletions in parkinsonism.
   Neurobiol Dis. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. JAIN S , Goldstein DS
    Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesis.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
11. VERHAAR R , Drukarch B, Bol JG, Jongenelen CA, et al
    Increase in endoplasmic reticulum-associated tissue transglutaminase and enzymatic activation in a cellular model of Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. CEDERFJALL E , Sahin G, Kirik D
    Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. CERSOSIMO MG , Benarroch EE
    Pathological correlates of gastrointestinal dysfunction in Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. KELLS AP , Forsayeth J, Bankiewicz KS
    Glial-derived neurotrophic factor gene transfer for Parkinson's disease: Anterograde distribution of AAV2 vectors in the primate brain.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. SAKAKIBARA R , Tateno F, Kishi M, Tsuyuzaki Y, et al
    Pathophysiology of bladder dysfunction in Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. MORAN A , Stein E, Tischler H, Bar-Gad I, et al
    Decoupling neuronal oscillations during subthalamic nucleus stimulation in the parkinsonian primate.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
17. BOTTA-ORFILA T , Tolosa E, Gelpi E, Sanchez-Pla A, et al
    Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
18. POUCLET H , Lebouvier T, Coron E, Varannes SB, et al
    A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. FOULDS PG , Yokota O, Thurston A, Davidson Y, et al
    Post mortem cerebrospinal fluid alpha-synuclein levels are raised in multiple system atrophy and distinguish this from the other alpha-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. SIDDIQUI A , Mallajosyula JK, Rane A, Andersen JK, et al
    Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: implications for early intervention on disease progression.
    Neurobiol Dis. 2011;43:527-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
21. NUBER S , Petrasch-Parwez E, Arias-Carrion O, Koch L, et al
    Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
22. BARTUS RT , Brown L, Wilson A, Kruegel B, et al
    Properly scaled and targeted AAV-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ARMENTERO MT , Levandis G, Bazzini E, Cerri S, et al
    Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. ONO K , Ikeda T, Takasaki JI, Yamada M, et al
    Familial Parkinson disease mutations influence alpha-synuclein assembly.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. FARRELL TC , Cario CL, Milanese C, Vogt A, et al
    Evaluation of spontaneous propulsive movement as a screening tool to detect rescue of Parkinsonism phenotypes in zebrafish models.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. ALVAREZ-ERVITI L , Seow Y, Schapira AH, Gardiner C, et al
    Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission.
    Neurobiol Dis. 2011;42:360-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
27. POLITIS M , Loane C, Wu K, Brooks DJ, et al
    Serotonergic mediated body mass index changes in Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
28. ILIJIC E , Guzman JN, Surmeier DJ
    The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
29. GIORGI M , Melchiorri G, Nuccetelli V, D'Angelo V, et al
    PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: A key step in parkinsonism physiopathology.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
30. MANGANO EN , Peters S, Litteljohn D, So R, et al
    Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
31. PERNECZKY R , Ghosh BC, Hughes L, Carpenter RH, et al
    Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. FRANCARDO V , Recchia A, Popovic N, Andersson D, et al
    Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. KHAINDRAVA V , Salin P, Melon C, Ugrumov M, et al
    High frequency stimulation of the subthalamic nucleus impacts adult neurogenesis in a rat model of Parkinson's disease.
    Neurobiol Dis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
34. ARNOLD B , Cassady SJ, VanLaar VS, Berman SB, et al
    Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model.
    Neurobiol Dis. 2011;41:189-200.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. AMO T , Sato S, Saiki S, Wolf AM, et al
    Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects.
    Neurobiol Dis. 2011;41:111-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
36. NAVAILLES S , Bioulac B, Gross C, De Deurwaerdere P, et al
    Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. GREENE JG
    Current status and future directions of gene expression profiling in Parkinson's disease.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. L'EPISCOPO F , Tirolo C, Testa N, Caniglia S, et al
    Reactive astrocytes and Wnt/beta-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
39. WARRE R , Thiele S, Talwar S, Kamal M, et al
    Altered Function of Glutamatergic Cortico-Striatal Synapses Causes Output Pathway Abnormalities in a Chronic Model of Parkinsonism.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. PLOWEY ED , Chu CT
    Synaptic Dysfunction in Genetic Models of Parkinson's Disease: A Role for Autophagy?
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. WREE A , Mix E, Hawlitschka A, Antipova V, et al
    Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. KALAITZAKIS ME , Walls AJ, Pearce RK, Gentleman SM, et al
    Striatal Abeta peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
43. BURGUILLOS MA , Hajji N, Englund E, Persson A, et al
    Apoptosis-inducing factor mediates dopaminergic cell death in response to lps-induced inflammatory stimulus. Evidence in Parkinson's disease patients.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. CASTRIOTO A , Meaney C, Hamani C, Mazzella F, et al
    The Dominant-STN phenomenon in bilateral STN DBS for Parkinson's disease.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
45. CHU Y , Mickiewicz AL, Kordower JH
    alpha-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's disease.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. CHAN V , Starr PA, Turner RS
    Bursts and oscillations as independent properties of neural activity in the parkinsonian Globus Pallidus internus.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
47. MARCELLINO D , Lindqvist E, Schneider M, Muller CE, et al
    Chronic A(2A) antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SIDDIQUI A , Mallajosyula JK, Rane A, Andersen JK, et al
    Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: Implications for early intervention on disease progression.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
49. AMBEGAOKAR SS , Roy B, Jackson GR
    Neurodegenerative models in Drosophila: Polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. POLITIS M , Wu K, Loane C, Kiferle L, et al
    Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo(11)C-DASB PET study.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. REETZ K , Tadic V, Kasten M, Bruggemann N, et al
    Structural imaging in the presymptomatic stage of genetically determined parkinsonism.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. VAN DIJK KD , Teunissen CE, Drukarch B, Jimenez CR, et al
    Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. RYLANDER D , Iderberg H, Li Q, Dekundy A, et al
    A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
54. MOCKO JB , Kern A, Moosmann B, Behl C, et al
    Phenothiazines interfere with dopaminergic neurodegeneration in Caenorhabditis elegans models of Parkinson's disease.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. YAO C , El Khoury R, Wang W, Byrd TA, et al
    LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
56. CILIA R , Ko JH, Cho SS, van Eimeren T, et al
    Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. GREENE JG , Dingledine R, Greenamyre JT
    Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. BLESA J , Juri C, Collantes M, Penuelas I, et al
    Progression of Dopaminergic Depletion in a Model of MPTP-Induced Parkinsonism in Non-Human Primates. An (18)F-DOPA and (11)C-DTBZ PET study.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. BAYERSDORFER F , Voigt A, Schneuwly S, Botella JA, et al
    Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. STORVIK M , Arguel MJ, Schmieder S, Delerue-Audegond A, et al
    Genes regulated in MPTP-treated macaques and human Parkinson's disease suggest a common signature in prefrontal cortex.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. DE LELLA EZCURRA AL , Chertoff M, Ferrari C, Graciarena M, et al
    Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.
    Neurobiol Dis. 2010;37:630-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
62. ZHU W , Li X, Xie W, Luo F, et al
    Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration.
    Neurobiol Dis. 2010;37:307-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
63. NAVAILLES S , Bioulac B, Gross C, De Deurwaerdere P, et al
    Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. TANJI K , Kamitani T, Mori F, Kakita A, et al
    TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies.
    Neurobiol Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim.

Amedeo is a Flying Publisher website.    Design: